Erika Pearce, Ph.D., scientific director, BKI Institute for Cancer Immunotherapy Molecular Biology; professor of oncology, biochemistry and molecular biology, Johns Hopkins University School of Medicine

9:00 a.m.: Shane Krska, Ph.D., discovery chemistry, Merck, Accelerating Drug Discovery Through Innovations in Catalysis and Industry-Academic Partnerships

9:20 a.m.: Martin Tomanik, Ph.D., assistant professor, department of chemistry, New York University, Radical-Triggered Functional Group Translocation and Total Synthesis of Talaromyolide D

9:40 a.m.: Danielle Schultz, Ph.D., process chemistry, Merck, Harnessing Collaboration and Enabling Technologies to Move Fast and Break Boundaries in Drug Discovery

10:00 a.m.: Jiankun Lyu, Ph.D., assistant professor and head of lab, The Rockefeller University, Virtual Screening of 100+-Billion-Molecule Libraries for Prospective Ligand Discovery

10:45 a.m.: Daniel Keedy, Ph.D., associate professor, City University of New York, High-Throughput Mapping of Ligandability in Allosteric Enzymes by Crystallographic Fragment Screening

11:05 a.m.: Yacob Gomez Llorente, Ph.D., and Sandra Gabelli, Ph.D, structural chemistry, Merck, Driving Pharmaceutical Breakthroughs through Structural Biology: Enlicitide a case study

11:25 a.m.: Chi-Min (Mimi) Ho, Ph.D., assistant professor, department of microbiology and immunology, Columbia University, Molecular Basis of Malarial Host-Cell Invasion

11:45 a.m.: Kaavya Krishna Kumar, Ph.D., assistant professor of pharmacology, Weill Cornell Medicine, Design of Safer Cannabinoid Receptor Ligands

12:05 p.m.: Michael Lazarus, Ph.D., associate professor of pharmacological sciences, the Icahn School of Medicine at Mount Sinai, Structural and Biochemical Studies on the Enigmatic YicC Family of RNases

2:00 p.m.: Heeseon An, Ph.D., assistant member, chemical biology program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Comprehensive Chemoproteomics Unveils Selective HMG-CoA Synthase1 Inhibitors for Targeting Mevalonate Metabolism in Cancer

2:20 p.m.; Christine Iok In Chio, Ph.D., assistant professor of genetics and development, Institute for Cancer Genetics, Columbia University Irving Medical Center, Redox Control of Systemic Metabolism in Cancer and Metabolic Disease

2:40 p.m.: Ralph Kleiner, Ph.D., associate professor of chemistry, Princeton University, Illuminating RNA Biology with Metabolically Incorporated Ribonucleoside Probes

3:00 p.m.: Jennifer Hickey, Ph.D., discovery chemistry, Merck, Oral Macrocyclic Peptide Inhibitors of IL-1β

David M. Altshuler, M.D., Ph.D., executive vice president; chief scientific officer, Vertex Pharmaceuticals

Hari Shroff, Ph.D., senior investigator, molecular tools and imaging, Howard Hughes Medical Institute

Zehao Zhang, graduate fellow, Cao Lab, The Rockefeller University

Don Cleveland, Ph.D., chair, department of cellular and molecular medicine, University of California at San Diego; head, laboratory for cell biology, Ludwig Cancer Research

Charles Swanton, Ph.D., FRCP, deputy clinical director, The Francis Crick Institute